Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Eiger BioPharmaceuticals, Inc. | Financial_Report.xls |
| EX-31.2 - EX-31.2 - Eiger BioPharmaceuticals, Inc. | d843760dex312.htm |
| EX-31.1 - EX-31.1 - Eiger BioPharmaceuticals, Inc. | d843760dex311.htm |
| EX-32.1 - EX-32.1 - Eiger BioPharmaceuticals, Inc. | d843760dex321.htm |
| EX-10.34 - EX-10.34 - Eiger BioPharmaceuticals, Inc. | d843760dex1034.htm |
| EX-10.35 - EX-10.35 - Eiger BioPharmaceuticals, Inc. | d843760dex1035.htm |
| EX-10.32 - EX-10.32 - Eiger BioPharmaceuticals, Inc. | d843760dex1032.htm |
| EX-10.33 - EX-10.33 - Eiger BioPharmaceuticals, Inc. | d843760dex1033.htm |
| 10-K - 10-K - Eiger BioPharmaceuticals, Inc. | d843760d10k.htm |
| EX-23.1 - EX-23.1 - Eiger BioPharmaceuticals, Inc. | d843760dex231.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Paul B. Cleveland, President and Chief Financial Officer of Celladon Corporation (the “Registrant”), do hereby certify in accordance with 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, based upon my knowledge:
| (1) | this Annual Report on Form 10-K of the Registrant, to which this certification is attached as an exhibit (the “Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m); and |
| (2) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant. |
Date: March 31, 2015
| /s/ Paul B. Cleveland |
| Paul B. Cleveland |
| President and Chief Financial Officer |
This certification accompanies the Form 10-K to which it relates, is not deemed filed with the Securities Exchange Commission and is not incorporated by reference into any filing of the Registrant under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-K), irrespective of any general incorporation language contained in such filing.